Embryonic stem cell bill is dead

The United States Senate voted to pass S. 5, the "Stem Cell Research Enhancement Act." Tony Perkins, president of Family Research Council, issued the following statement:

"Rather than defend human dignity, a majority of Senators approved legislation to force taxpayers to fund research that requires the destruction of human life. Nevertheless, this bill fell short of the two thirds majority necessary to override the president's promised veto.

"I welcome the ethical stand thirty four Senators embraced to oppose forcing taxpayers to fund research that requires the destruction of embryonic human life. I particularly applaud the support of Republicans Mitch McConnell and Sam Brownback, as well as Democrats Ben Nelson and Bob Casey for their hard work.

"Now that S. 5 is dead, we should immediately expand on adult stem cell research that is treating people now, like the study just published yesterday in JAMA in which diabetic patients were treated successfully. This study done in Brazil showed that, for the first time, adult stem cells were used to treat 13 patients with diabetes. This is precisely the type of stem cell research we should be expanding here in the U.S."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Assessing recurrence risk with ctDNA-based MRD detection in NSCLC patients